Records containing: Hepatitis C
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2008-05-07A Phase 1 Study of Chimeric Anti-Phosphatidylserine Monoclonal Antibody (Bavituximab) in Patients Chronically Infected With Hepatitis C Virus (HCV) Who Are Non-Responders or Relapsers After Treatment With Pegylated Interferon Plus Ribavirin
-
CLINICAL_TRIALS study record update · 2008-04-17A Phase 4 Open-Label Pilot Study of the Safety and Tolerability of High Dosage of CIFN Plus RBV Administered Daily for 48 Weeks in HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Pegylated Interferon Alfa Plus RBV Therapy
-
CLINICAL_TRIALS study record update · 2008-04-14An Open-Label, Single-Dose, Parallel-Group Study of the Pharmacokinetics and Safety of HCV-796 in Subjects With Chronic Hepatic Impairment and in Matched Healthy Adults
-
CLINICAL_TRIALS study record update · 2008-04-10Exploratory Study of AVI-4065 Injection to Design Therapeutic Dosing for Chronic Active HCV Patients
-
CLINICAL_TRIALS study record update · 2008-03-07A Phase I Study of Low Dose Interleukin 2 (IL-2)Monotherapy, Followed by IL-2 Plus PEG-IFN/RBV In Chronic Hepatitis C Virus Genotype I Infection
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2008-03-04Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV
-
CLINICAL_TRIALS study record update · 2008-03-04Natural History of Chronic Hepatitis C Among Volunteer Blood Donors
-
CLINICAL_TRIALS study record update · 2008-03-04Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies
-
CLINICAL_TRIALS study record update · 2008-03-04Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan
-
CLINICAL_TRIALS study record update · 2008-03-04A Randomized, Controlled Study to Assess the Impact of Highly Active Antiretroviral Therapy to Hepatitis C Therapy in Patients Coinfected With HIV-1 and Treated With Peginterferon Alpha-2b and Ribavirin
-
CLINICAL_TRIALS study record update · 2008-02-26Role of Rapid Virologic Response in Determining Treatment Duration of Peginterferon Alfa-2b/Ribavirin in Chronic Hepatitis C Genotype 4
-
CLINICAL_TRIALS study record update · 2008-02-20Single and Multiple Dose Escalation Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Administered Silymarin (Legalon) in Non-Cirrhotic Subjects With Chronic Hepatitis C or Non-Alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2008-02-12Open, Randomized, Multicenter Phase IV Study to Evaluate Efficacy and Safety to Extend Treatment 24 Weeks in co-Infected HIV-HCV Patients Genotype 1 and/or 4
-
CLINICAL_TRIALS study record update · 2008-02-08Clinical Trial of the Efficacy of Pegylated Interferon (PEG-IFNα-2a) Alone in Egyptian Patients With Acute Hepatitis C
-
CLINICAL_TRIALS study record update · 2008-01-15ClinicalTrials.gov study NCT00039962
-
CLINICAL_TRIALS study record update · 2008-01-15ClinicalTrials.gov study NCT00040027
-
CLINICAL_TRIALS study record update · 2008-01-11A Randomized Trial Comparing a Short Course Versus Standard Treatment in Patients With Chronic Hepatitis C Virus Infection
-
CLINICAL_TRIALS study record update · 2007-12-21A Phase 2 Study of VX-950 in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects With Hepatitis C
-
CLINICAL_TRIALS study record update · 2007-12-21A Phase 1b Viral Kinetic Study of VX-950 and Peginterferon in Hepatitis C
-
CLINICAL_TRIALS study record update · 2007-12-21A Phase 2b Study of Merimepodib in Combination With Pegylated Interferon Alfa-2a (Pegasys®) and Ribavirin in Subjects With Chronic Hepatitis C Non-Responsive to Prior Therapy With Pegylated Interferon Alfa and Ribavirin
-
CLINICAL_TRIALS study record update · 2007-12-21A Randomized, Placebo Controlled, Phase 1b Trial to Evaluate the Safety and Pharmacokinetics of NOV-205 in Chronic Viral Hepatitis C Subjects (Genotype 1) Who Have Failed Treatment With Pegylated Interferon Plus Ribavirin
-
CLINICAL_TRIALS study record update · 2007-12-14Reducing Depressive Symptoms During HCV Therapy: A Randomized Study
-
CLINICAL_TRIALS study record update · 2007-11-30Health Behavior Feedback Study for Veterans With Hepatitis C
-
CLINICAL_TRIALS study record update · 2007-08-23Phase 2 Study of Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C
-
CLINICAL_TRIALS study record update · 2007-08-01Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection